Journe, Fabrice ; Université de Mons > Faculté de Médecine et de Pharmacie > Histologie ; Université de Mons > Faculté des Sciences > FS - Service du Doyen
Alonzo TA (2005) Standards for reporting prognostic tumor marker studies. J Clin Oncol Off J Am Soc Clin Oncol 23: 9053-9054.
Balch CM, Gershenwald JE, Soong S-J, Thompson JF, Atkins MB, Byrd DR, Buzaid AC, Cochran AJ, Coit DG, Ding S, Eggermont AM, Flaherty KT, Gimotty PA, Kirkwood JM, McMasters KM, Mihm Jr MC, Morton DL, Ross MI, Sober AJ, Sondak VK (2009) Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol Off J Am Soc Clin Oncol 27: 6199-6206.
Bolander A, Agnarsdóttir M, Strömberg S, Ponten F, Hesselius P, Uhlen M, Bergqvist M (2008) The protein expression of TRP-1 and galectin-1 in cutaneous malignant melanomas. Cancer Genomics Proteomics 5: 293-300.
Brendle A, Lei H, Brandt A, Johansson R, Enquist K, Henriksson R, Hemminki K, Lenner P, Försti A (2008) Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker. Carcinogenesis 29: 1394-1399.
Budczies J, Klauschen F, Sinn BV, Gyorffy B, Schmitt WD, Darb-Esfahani S, Denkert C (2012) Cutoff Finder: a comprehensive and straightforward web application enabling rapid biomarker cutoff optimization. PLoS One 7: e51862.
Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J, Wittwer CT (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55: 611-622.
Carreira S, Goodall J, Aksan I, La Rocca SA, Galibert M-D, Denat L, Larue L, Goding CR (2005) Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression. Nature 433: 764-769.
El Hajj P, Journe F, Wiedig M, Laios I, Salès F, Galibert M-D, Van Kempen LC, Spatz A, Badran B, Larsimont D, Awada A, Ghanem G (2013) Tyrosinase-related protein 1 mRNA expression in lymph node metastases predicts overall survival in high-risk melanoma patients. Br J Cancer 108(8): 1641-1647.
Fang D, Hallman J, Sangha N, Kute TE, Hammarback JA, WhiteWL, Setaluri V (2001) Expression of microtubule-associated protein 2 in benign and malignant melanocytes: implications for differentiation and progression of cutaneous melanoma. Am J Pathol 158: 2107-2115.
Gamazon ER, Ziliak D, Im HK, LaCroix B, Park DS, Cox NJ, Huang RS (2012) Genetic architecture of microRNA expression: implications for the transcriptome and complex traits. Am J Hum Genet 90: 1046-1063.
Ghanem G, Fabrice J (2011) Tyrosinase related protein 1 (TYRP1/gp75) in human cutaneous melanoma. Mol Oncol 5: 150-155.
Gould Rothberg BE, Bracken MB, Rimm DL (2009) Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis. J Natl Cancer Inst 101: 452-474.
Grignol V, Fairchild ET, Zimmerer JM, Lesinski GB, Walker MJ, Magro CM, Kacher JE, Karpa VI, Clark J, Nuovo G, Lehman A, Volinia S, Agnese DM, Croce CM, Carson 3rd WE (2011) miR-21 and miR-155 are associated with mitotic activity and lesion depth of borderline melanocytic lesions. Br J Cancer 105: 1023-1029.
Gu S, KayMA (2010) How do miRNAs mediate translational repression? Silence 1: 11.
Jin Y, Lee CGL (2013) Single nucleotide polymorphisms associated with microRNA Regulation. Biomolecules 3: 287-302.
Journe F, Id Boufker H, Van Kempen L, Galibert M-D, Wiedig M, Salès F, Theunis A, Nonclercq D, Frau A, Laurent G, Awada A, Ghanem G (2011) TYRP1 mRNA expression in melanoma metastases correlates with clinical outcome. Br J Cancer 105: 1726-1732.
Kashani-Sabet M, Venna S, Nosrati M, Rangel J, Sucker A, Egberts F, Baehner FL, Simko J, Leong SPL, Haqq C, Hauschild A, Schadendorf D, Miller 3rd JR, Sagebiel RW (2009) A multimarker prognostic assay for primary cutaneous melanoma. Clin Cancer Res Off J Am Assoc Cancer Res 15: 6987-6992.
Levati L, Alvino E, Pagani E, Arcelli D, Caporaso P, Bondanza S, Di Leva G, Ferracin M, Volinia S, Bonmassar E, Croce CM, D'Atri S (2009) Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155. Int J Oncol 35: 393-400.
Li J, Liu Y, Xin X, Kim TS, Cabeza EA, Ren J, Nielsen R, Wrana JL, Zhang Z (2012) Evidence for positive selection on a number of microRNA regulatory interactions during recent human evolution. PLoS Genet 8: e1002578.
McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM (2005) REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer 93: 387-391.
Meyer S, Fuchs TJ, Bosserhoff AK, Hofstadter F, Pauer A, Roth V, Buhmann JM, Moll I, Anagnostou N, Brandner JM, Ikenberg K, Moch H, Landthaler M, Vogt T, Wild PJ (2012) A seven-marker signature and clinical outcome in malignant melanoma: a large-scale tissue-microarray study with two independent patient cohorts. PLoS One 7(6): e38222.
Osman A (2012) MicroRNAs in health and disease-basic science and clinical applications. Clin Lab 58: 393-402.
Primot A, Mogha A, Corre S, Roberts K, Debbache J, Adamski H, Dreno B, Khammari A, Lesimple T, Mereau A, Goding CR, Galibert MD (2010) ERK-regulated differential expression of the Mitf 6a/b splicing isoforms in melanoma. Pigment Cell Melanoma Res 23: 93-102.
Preskill C, Weidhaas JB (2013) SNPs in microRNA binding sites as prognostic and predictive cancer biomarkers. Crit Rev Oncog 18: 327-340.
Reich DE, Gabriel SB, Altshuler D (2003) Quality and completeness of SNP databases. Nat Genet 33: 457-458.
Ruike Y, Ichimura A, Tsuchiya S, Shimizu K, Kunimoto R, Okuno Y, Tsujimoto G (2008) Global correlation analysis for micro-RNA and mRNA expression profiles in human cell lines. J Hum Genet 53: 515-523.
Sayed D, Abdellatif M (2011) MicroRNAs in development and disease. Physiol Rev 91: 827-887.
Segura MF, Belitskaya-Lévy I, Rose AE, Zakrzewski J, Gaziel A, Hanniford D, Darvishian F, Berman RS, Shapiro RL, Pavlick AC, Osman I, Hernando E (2010) Melanoma microRNA signature predicts post-recurrence survival. Clin Cancer Res Off J Am Assoc Cancer Res 16: 1577-1586.
Selbach M, Schwanhaüsser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N (2008) Widespread changes in protein synthesis induced by microRNAs. Nature 455: 58-63.
Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R (2006) Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 20: 515-524.